Core Outcome Measurement Set for Shared Decision Making in Rheumatic and Musculoskeletal Conditions: A Scoping Review to Identify Candidate Instruments
…, F Guillemin, SJ Bartlett, DB Berthelsen… - Seminars in Arthritis and …, 2023 - Elsevier
OBJECTIVES Shared decision making (SDM) is a central tenet in rheumatic and musculoskeletal
care. The lack of standardization regarding SDM instruments and outcomes in clinical …
care. The lack of standardization regarding SDM instruments and outcomes in clinical …
[HTML][HTML] Perceived benefits, barriers, and facilitators of a digital patient-reported outcomes tool for routine diabetes care: protocol for a national, multicenter, mixed …
…, N Balk-Møller, DB Berthelsen… - JMIR research …, 2021 - researchprotocols.org
Background: There is growing evidence that digital patient-reported outcome (PRO)
questionnaires and PRO-based decision support tools may help improve the active engagement of …
questionnaires and PRO-based decision support tools may help improve the active engagement of …
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety …
DB Berthelsen, LS Simon, JPA Ioannidis… - Seminars in Arthritis and …, 2023 - Elsevier
Objectives To develop an understanding of the concept of safety/harms experienced by
patients involved in clinical trials for their rheumatic and musculoskeletal diseases (RMDs) and …
patients involved in clinical trials for their rheumatic and musculoskeletal diseases (RMDs) and …
Identifying possible outcome domains from existing outcome measures to inform an OMERACT core domain set for safety in rheumatology trials
L Klokker, DB Berthelsen, T Woodworth… - The Journal of …, 2019 - jrheum.org
Objective. The Outcome Measures in Rheumatology (OMERACT) Safety Working Group
objective was to identify harm domains from existing outcome measurements in rheumatology. …
objective was to identify harm domains from existing outcome measurements in rheumatology. …
[HTML][HTML] Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows
…, E Balay-Dustrude, C Bekker, DB Berthelsen… - Seminars in Arthritis and …, 2024 - Elsevier
Objective To describe the evolution of the OMERACT Fellows Program (OM FP) and to evaluate
the innovative changes implemented in the 2023 program. Methods The OM FP, the first …
the innovative changes implemented in the 2023 program. Methods The OM FP, the first …
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials
…, A Jayatilleke, I Hmamouchi, DB Berthelsen… - Seminars in Arthritis and …, 2024 - Elsevier
Objective To gain consensus on the definitions and descriptions of the domains of the
Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials …
Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials …
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set
…, D Meyer, D Constien, DB Berthelsen… - Seminars in Arthritis and …, 2024 - Elsevier
… l , Daniel Meyer m , Deb Constien n , Dorthe B. Berthelsen o p q , Grayson Schultz n , Ingrid
de Groot r , Joan Weiner n , Kate Mather k , Maarten de Wit s … Maria E. Suarez-Almazor c …
de Groot r , Joan Weiner n , Kate Mather k , Maarten de Wit s … Maria E. Suarez-Almazor c …
Controversy and Debate on Meta-epidemiology. Paper 1: Treatment effect sizes vary in randomized trials depending on the type of outcome measure
DB Berthelsen, E Ginnerup-Nielsen, C Juhl… - Journal of clinical …, 2020 - Elsevier
… Author links open overlay panel Dorthe B. Berthelsen a , Elisabeth Ginnerup-Nielsen a ,
Carsten Juhl b c , Hans Lund d , Marius Henriksen a e , Asbjørn Hróbjartsson f , Sabrina M. …
Carsten Juhl b c , Hans Lund d , Marius Henriksen a e , Asbjørn Hróbjartsson f , Sabrina M. …
Harms reported by patients in rheumatology drug trials: a systematic review of randomized trials in the cochrane library from an OMERACT working group
DB Berthelsen, TG Woodworth, N Goel… - Seminars in Arthritis and …, 2021 - Elsevier
… Author links open overlay panel Dorthe B. Berthelsen a b , Thasia G. Woodworth c , Niti
Goel d , John PA Ioannidis e , Peter Tugwell f , Dan Devoe g , Paula Williamson h , Caroline …
Goel d , John PA Ioannidis e , Peter Tugwell f , Dan Devoe g , Paula Williamson h , Caroline …
Controversy and Debate on Meta-epidemiology. Paper 3: Causal inference from meta-epidemiology: a reasonable goal, or wishful thinking?
R Christensen, DB Berthelsen - Journal of Clinical Epidemiology, 2020 - jclinepi.com
We thank Professor Robert D. Herbert for his interest in our study [1] and for his insightful
commentary [2], which elaborates on a general criticism against the usefulness of meta-…
commentary [2], which elaborates on a general criticism against the usefulness of meta-…